Results 291 to 300 of about 1,166,644 (417)

Ethnomedicinal Uses, Phytochemistry, Pharmacological Activities, and Toxicology of the Subfamily Gomphrenoideae (Amaranthaceae): A Comprehensive Review

open access: yesChemistry &Biodiversity, EarlyView.
ABSTRACT The subfamily Gomphrenoideae is composed of about 480 accepted species, many of which have been historically used as medicinal plants, reason why they have been studied in terms of chemical profile, biological activity, and safety. This review consolidates the advances in research on this subfamily over the past 47 years, emphasizing its ...
Dayanna Isabel Araque Gelves   +3 more
wiley   +1 more source

Steerable Delivery Sheath for Optimized LAA Closure: First Experience and Procedural Outcomes

open access: yesCatheterization and Cardiovascular Interventions, EarlyView.
ABSTRACT Background The new Amplatzer Steerable Delivery Sheath is a delivery system designed to improve ease‐of‐use and procedural results of left atrial appendage closure (LAAC). We aimed to compare procedural results after switching our LAAC program at a tertiary care center with the Amulet device to the Steerable Delivery Sheath, with a control ...
Matthias Mezger   +4 more
wiley   +1 more source

Potassium deficiency in chronic renal failure.

open access: yesKidney International, 1973
Gordon L. Bilbrey   +5 more
semanticscholar   +1 more source

Dual Antiplatelet Therapy Prior to Percutaneous Coronary Intervention for Acute Coronary Syndrome: Prevalence and Outcomes in Contemporary Practice

open access: yesCatheterization and Cardiovascular Interventions, EarlyView.
ABSTRACT Background Dual antiplatelet therapy (DAPT) is standard following percutaneous coronary intervention (PCI) for acute coronary syndrome (ACS). Preloading is the practice of administering both aspirin and a P2Y12 inhibitor before PCI. DAPT preloading is common practice, however clinical trial evidence demonstrating benefit is lacking.
Shi Hui Goh   +11 more
wiley   +1 more source

Troponin efficacy in the diagnosis of acute coronary syndrome in patients with chronic renal failure. [PDF]

open access: yesMedicine (Baltimore)
Ermete Güler E   +4 more
europepmc   +1 more source

PCSK‐9 Inhibitors Can Significantly Improve the Coronary Slow Flow Caused by Elevated Lipoprotein (a) in ST‐Elevation Myocardial Infarction Patients With Chronic Kidney Disease

open access: yesCatheterization and Cardiovascular Interventions, EarlyView.
ABSTRACT Background Coronary slow flow and no reflow significantly predict poor prognosis in acute myocardial infarction (AMI) patients, especially those with chronic kidney disease (CKD). Early identification of factors contributing to these conditions can mitigate ischemic events and improve outcomes.
Hao Xu   +5 more
wiley   +1 more source

Combination of Fushengong decoction with Western medicine on patients with chronic renal failure: An observational study. [PDF]

open access: yesMedicine (Baltimore)
Zou B   +10 more
europepmc   +1 more source

Home - About - Disclaimer - Privacy